These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 14239958)

  • 1. SOME FACTORS IN RENAL AND RENOPRIVAL HYPERTENSION.
    DUSTAN HP; PAGE IH
    J Lab Clin Med; 1964 Dec; 64():948-59. PubMed ID: 14239958
    [No Abstract]   [Full Text] [Related]  

  • 2. MECHANISMS OF HYPERTENSION IN RENOPRIVAL MAN.
    MERRILL JP; SCHUPAK E
    Can Med Assoc J; 1964 Jan; 90(4):328-32. PubMed ID: 14111746
    [No Abstract]   [Full Text] [Related]  

  • 3. EFFECT OF BILATERAL NEPHRECTOMY AND KIDNEY TRANSPLANTATION ON HYPERTENSION IN MAN.
    KOLFF WJ; NAKAMOTO S; POUTASSE EF; STRAFFON RA; FIGUEROA JE
    Circulation; 1964 Aug; 30():SUPPL 2:23-35. PubMed ID: 14187061
    [No Abstract]   [Full Text] [Related]  

  • 4. THE HAEMODYNAMIC EFFECTS OF SODIUM AMOBARBITAL IN HYPERTENSION.
    TUCKMAN J; SHILLINGFORD J
    Br Heart J; 1964 Mar; 26(2):206-12. PubMed ID: 14132023
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and maintenance of renal hypertension in normal and guanethidine sympathectomized rats.
    Douglas JR; Johnson EM; Marshall GR; Heist J; Hartman BK; Needleman P
    Circ Res; 1975 Jun; 36(6 Suppl 1):171-8. PubMed ID: 1093753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DRUG THERAPY OF CIRCULATORY DISEASES].
    TAKATSU T
    Naika; 1964 Mar; 13():465-79. PubMed ID: 14125381
    [No Abstract]   [Full Text] [Related]  

  • 7. HYPERTENSION DUE TO RENAL ISCHEMIA.
    GOLDBLATT H
    Bull N Y Acad Med; 1964 Oct; 40(10):745-58. PubMed ID: 14209384
    [No Abstract]   [Full Text] [Related]  

  • 8. FLUID RETENTION PRODUCED BY GUANETHIDINE; CHANGES IN BODY EXCHANGEABLE SODIUM, BLOOD VOLUME, AND CREATININE CLEARANCE.
    SMITH AJ
    Circulation; 1965 Apr; 31():490-6. PubMed ID: 14275986
    [No Abstract]   [Full Text] [Related]  

  • 9. [RENOPRIVAL HYPERTENSION AND RENAL HYPERTENSION].
    OSHIMA K; SUGINO N
    Naika; 1963 Dec; 12():1011-6. PubMed ID: 14100316
    [No Abstract]   [Full Text] [Related]  

  • 10. [SEVERE NEUROLOGICAL SIDE-EFFECTS IN HYPOTENSION THERAPY].
    BOETTIGER LE; MALMBORG RO; MICHAELI EW
    Nord Med; 1964 Apr; 71():523-5. PubMed ID: 14131560
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypertension and unilateral parenchymal renal disease. Evidence for abnormal vasoconstriction-volume interaction.
    Vaughan ED; Bühler FR; Laragh JH; Sealey JE; Gavras H; Baer L
    JAMA; 1975 Sep; 233(11):1177-83. PubMed ID: 1174172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EXPERIENCES WITH THE LONG-TERM USE OF METHYLDOPA ("ALDOMET") IN HYPERTENSION.
    MEIRING PD
    Med J Aust; 1965 Mar; 1(12):416-9. PubMed ID: 14274397
    [No Abstract]   [Full Text] [Related]  

  • 13. Control of renin release in experimental hypertension.
    Ayers CR; Harris RH; Lefer LG
    Circ Res; 1969 May; 24(5 Suppl):103-12. PubMed ID: 5772094
    [No Abstract]   [Full Text] [Related]  

  • 14. TREATMENT OF HYPERTENSION WITH RESERPINE, THIAZIDE DERIVATIVES, AND GUANETHIDINE.
    SEEDAT YK; BHIKHA M; PATEL PL; PILLAY VK
    S Afr Med J; 1964 Apr; 38():282-4. PubMed ID: 14144293
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diverse effect of hydrochlorothiazide in relation to the hypotensive activity of reserpine, rescinnamine, syrosingopine, 1, 4-dihydrazino-phthlazine (alone or associated with reserpine), hexamethonium and guanethidine].
    MIELE E; MARMO E; PREZIOSI P
    Arch Ital Sci Farmacol; 1961 Oct; 11():367-70. PubMed ID: 14473573
    [No Abstract]   [Full Text] [Related]  

  • 16. [ACUTE MALIGNANT HYPERTENSION WITH SECONDARY ALDOSTERONISM. A CASE IN A 31-YEAR-OLD MAN WITH CONGENITAL UNILATERAL RENAL HYPOPLASIA].
    PEDERSEN J; LINDENEG O; FISCHER S
    Ugeskr Laeger; 1964 Jan; 126():73-8. PubMed ID: 14115392
    [No Abstract]   [Full Text] [Related]  

  • 17. CLINICAL EXPERIENCE WITH THE MONOAMINE OXIDASE INHIBITOR, DL-SERINE-N-ISOPROPYLHYDRAZIDE (RO 4-1038), IN THE TREATMENT OF HYPERTENSION.
    MAXWELL MH; ROTH SI; GONICK HC; KLEEMAN CR
    Am Heart J; 1963 Aug; 66():151-63. PubMed ID: 14051181
    [No Abstract]   [Full Text] [Related]  

  • 18. [CONSIDERATIONS ON THE RENAL SIDE-EFFECTS DURING TREATMENT OF ARTERIAL HYPERTENSION].
    MIHAILESCU VV; CLEJ V; ENESCU R; SBENGHE S
    Med Interna (Bucur); 1964 Jan; 16():79-82. PubMed ID: 14132694
    [No Abstract]   [Full Text] [Related]  

  • 19. Problems in therapy for the hypertensive patient.
    Kim KE; Onesti G; Swartz C
    Geriatrics; 1973 Mar; 28(3):122-8. PubMed ID: 4691600
    [No Abstract]   [Full Text] [Related]  

  • 20. Is the peripheral sympatho-adrenal nervous system necessary for renal hypertension?
    Douglas JR; Johnson EM; Heist JF; Marshall GR; Needleman P
    J Pharmacol Exp Ther; 1976 Jan; 196(1):35-43. PubMed ID: 1246014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.